Global In Vitro Assays to Diagnose Infectious Diseases Market Growth (Status and Outlook) 2026-2032
The global In Vitro Assays to Diagnose Infectious Diseases market size is predicted to grow from US$ 3261 million in 2025 to US$ 2953 million in 2032; it is expected to grow at a CAGR of -1.4% from 2026 to 2032.
In Vitro Assays to Diagnose Infectious Diseases market refers to the use of diagnostic tests and devices to detect and diagnose infectious diseases in biological samples such as blood, urine, and other bodily fluids. These tests are performed in vitro, meaning outside of the body in a laboratory setting. The IVD market for infectious diseases includes a range of tests such as immunoassays, molecular diagnostics, and microbiology culture tests, among others. These tests aid in the identification of infectious agents such as bacteria, viruses, fungi, and parasites, and help in the management and treatment of infectious diseases.
Enzyme-Linked Immunosorbent Assay (ELISA): ELISA is a highly sensitive and specific assay that detects the presence of antigens or antibodies in patient samples. ELISA can be used to diagnose a wide range of infectious diseases, including HIV, hepatitis, and Lyme disease.
LPI (LP Information)' newest research report, the “In Vitro Assays to Diagnose Infectious Diseases Industry Forecast” looks at past sales and reviews total world In Vitro Assays to Diagnose Infectious Diseases sales in 2025, providing a comprehensive analysis by region and market sector of projected In Vitro Assays to Diagnose Infectious Diseases sales for 2026 through 2032. With In Vitro Assays to Diagnose Infectious Diseases sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world In Vitro Assays to Diagnose Infectious Diseases industry.
This Insight Report provides a comprehensive analysis of the global In Vitro Assays to Diagnose Infectious Diseases landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on In Vitro Assays to Diagnose Infectious Diseases portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global In Vitro Assays to Diagnose Infectious Diseases market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for In Vitro Assays to Diagnose Infectious Diseases and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global In Vitro Assays to Diagnose Infectious Diseases.
This report presents a comprehensive overview, market shares, and growth opportunities of In Vitro Assays to Diagnose Infectious Diseases market by product type, application, key players and key regions and countries.
Segmentation by Type:
In Vitro Assays to Diagnose Infectious Diseases market refers to the use of diagnostic tests and devices to detect and diagnose infectious diseases in biological samples such as blood, urine, and other bodily fluids. These tests are performed in vitro, meaning outside of the body in a laboratory setting. The IVD market for infectious diseases includes a range of tests such as immunoassays, molecular diagnostics, and microbiology culture tests, among others. These tests aid in the identification of infectious agents such as bacteria, viruses, fungi, and parasites, and help in the management and treatment of infectious diseases.
Enzyme-Linked Immunosorbent Assay (ELISA): ELISA is a highly sensitive and specific assay that detects the presence of antigens or antibodies in patient samples. ELISA can be used to diagnose a wide range of infectious diseases, including HIV, hepatitis, and Lyme disease.
LPI (LP Information)' newest research report, the “In Vitro Assays to Diagnose Infectious Diseases Industry Forecast” looks at past sales and reviews total world In Vitro Assays to Diagnose Infectious Diseases sales in 2025, providing a comprehensive analysis by region and market sector of projected In Vitro Assays to Diagnose Infectious Diseases sales for 2026 through 2032. With In Vitro Assays to Diagnose Infectious Diseases sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world In Vitro Assays to Diagnose Infectious Diseases industry.
This Insight Report provides a comprehensive analysis of the global In Vitro Assays to Diagnose Infectious Diseases landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on In Vitro Assays to Diagnose Infectious Diseases portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global In Vitro Assays to Diagnose Infectious Diseases market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for In Vitro Assays to Diagnose Infectious Diseases and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global In Vitro Assays to Diagnose Infectious Diseases.
This report presents a comprehensive overview, market shares, and growth opportunities of In Vitro Assays to Diagnose Infectious Diseases market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Immunoassay
- Molecular Diagnosis
- Others
- Streptococcus
- Clostridium Difficile
- Candida
- Tuberculosis
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- QIAGEN
- BD
- bioMerieux SA
- F. Hoffmann-La Roche, Ltd.
- Hologic, Inc. (Gen-Probe)
- Abbott
- Quidel Corp.?
- iemens Healthineers AG
- Bio-Rad Laboratories, Inc.
- Danaher Corp.
- OraSure Technologies, Inc
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global In Vitro Assays to Diagnose Infectious Diseases Market Size (2021-2032)
2.1.2 In Vitro Assays to Diagnose Infectious Diseases Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for In Vitro Assays to Diagnose Infectious Diseases by Country/Region (2021, 2025 & 2032)
2.2 In Vitro Assays to Diagnose Infectious Diseases Segment by Type
2.2.1 Immunoassay
2.2.2 Molecular Diagnosis
2.2.3 Others
2.2.4 In Vitro Assays to Diagnose Infectious Diseases Market Size by Type
2.2.4.1 In Vitro Assays to Diagnose Infectious Diseases Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Type (2021-2026)
2.3 In Vitro Assays to Diagnose Infectious Diseases Segment by Application
2.3.1 Streptococcus
2.3.2 Clostridium Difficile
2.3.3 Candida
2.3.4 Tuberculosis
2.3.5 Others
2.3.6 In Vitro Assays to Diagnose Infectious Diseases Market Size by Application
2.3.6.1 In Vitro Assays to Diagnose Infectious Diseases Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.6.2 Global In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Application (2021-2026)
3 IN VITRO ASSAYS TO DIAGNOSE INFECTIOUS DISEASES MARKET SIZE BY PLAYER
3.1 In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Player
3.1.1 Global In Vitro Assays to Diagnose Infectious Diseases Revenue by Player (2021-2026)
3.1.2 Global In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share by Player (2021-2026)
3.2 Global In Vitro Assays to Diagnose Infectious Diseases Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 IN VITRO ASSAYS TO DIAGNOSE INFECTIOUS DISEASES BY REGION
4.1 In Vitro Assays to Diagnose Infectious Diseases Market Size by Region (2021-2026)
4.2 Global In Vitro Assays to Diagnose Infectious Diseases Annual Revenue by Country/Region (2021-2026)
4.3 Americas In Vitro Assays to Diagnose Infectious Diseases Market Size Growth (2021-2026)
4.4 APAC In Vitro Assays to Diagnose Infectious Diseases Market Size Growth (2021-2026)
4.5 Europe In Vitro Assays to Diagnose Infectious Diseases Market Size Growth (2021-2026)
4.6 Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2021-2026)
5.2 Americas In Vitro Assays to Diagnose Infectious Diseases Market Size by Type (2021-2026)
5.3 Americas In Vitro Assays to Diagnose Infectious Diseases Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC In Vitro Assays to Diagnose Infectious Diseases Market Size by Region (2021-2026)
6.2 APAC In Vitro Assays to Diagnose Infectious Diseases Market Size by Type (2021-2026)
6.3 APAC In Vitro Assays to Diagnose Infectious Diseases Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2021-2026)
7.2 Europe In Vitro Assays to Diagnose Infectious Diseases Market Size by Type (2021-2026)
7.3 Europe In Vitro Assays to Diagnose Infectious Diseases Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases by Region (2021-2026)
8.2 Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size by Type (2021-2026)
8.3 Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL IN VITRO ASSAYS TO DIAGNOSE INFECTIOUS DISEASES MARKET FORECAST
10.1 Global In Vitro Assays to Diagnose Infectious Diseases Forecast by Region (2027-2032)
10.1.1 Global In Vitro Assays to Diagnose Infectious Diseases Forecast by Region (2027-2032)
10.1.2 Americas In Vitro Assays to Diagnose Infectious Diseases Forecast
10.1.3 APAC In Vitro Assays to Diagnose Infectious Diseases Forecast
10.1.4 Europe In Vitro Assays to Diagnose Infectious Diseases Forecast
10.1.5 Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Forecast
10.2 Americas In Vitro Assays to Diagnose Infectious Diseases Forecast by Country (2027-2032)
10.2.1 United States Market In Vitro Assays to Diagnose Infectious Diseases Forecast
10.2.2 Canada Market In Vitro Assays to Diagnose Infectious Diseases Forecast
10.2.3 Mexico Market In Vitro Assays to Diagnose Infectious Diseases Forecast
10.2.4 Brazil Market In Vitro Assays to Diagnose Infectious Diseases Forecast
10.3 APAC In Vitro Assays to Diagnose Infectious Diseases Forecast by Region (2027-2032)
10.3.1 China In Vitro Assays to Diagnose Infectious Diseases Market Forecast
10.3.2 Japan Market In Vitro Assays to Diagnose Infectious Diseases Forecast
10.3.3 Korea Market In Vitro Assays to Diagnose Infectious Diseases Forecast
10.3.4 Southeast Asia Market In Vitro Assays to Diagnose Infectious Diseases Forecast
10.3.5 India Market In Vitro Assays to Diagnose Infectious Diseases Forecast
10.3.6 Australia Market In Vitro Assays to Diagnose Infectious Diseases Forecast
10.4 Europe In Vitro Assays to Diagnose Infectious Diseases Forecast by Country (2027-2032)
10.4.1 Germany Market In Vitro Assays to Diagnose Infectious Diseases Forecast
10.4.2 France Market In Vitro Assays to Diagnose Infectious Diseases Forecast
10.4.3 UK Market In Vitro Assays to Diagnose Infectious Diseases Forecast
10.4.4 Italy Market In Vitro Assays to Diagnose Infectious Diseases Forecast
10.4.5 Russia Market In Vitro Assays to Diagnose Infectious Diseases Forecast
10.5 Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Forecast by Region (2027-2032)
10.5.1 Egypt Market In Vitro Assays to Diagnose Infectious Diseases Forecast
10.5.2 South Africa Market In Vitro Assays to Diagnose Infectious Diseases Forecast
10.5.3 Israel Market In Vitro Assays to Diagnose Infectious Diseases Forecast
10.5.4 Turkey Market In Vitro Assays to Diagnose Infectious Diseases Forecast
10.6 Global In Vitro Assays to Diagnose Infectious Diseases Forecast by Type (2027-2032)
10.7 Global In Vitro Assays to Diagnose Infectious Diseases Forecast by Application (2027-2032)
10.7.1 GCC Countries Market In Vitro Assays to Diagnose Infectious Diseases Forecast
11 KEY PLAYERS ANALYSIS
11.1 QIAGEN
11.1.1 QIAGEN Company Information
11.1.2 QIAGEN In Vitro Assays to Diagnose Infectious Diseases Product Offered
11.1.3 QIAGEN In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 QIAGEN Main Business Overview
11.1.5 QIAGEN Latest Developments
11.2 BD
11.2.1 BD Company Information
11.2.2 BD In Vitro Assays to Diagnose Infectious Diseases Product Offered
11.2.3 BD In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 BD Main Business Overview
11.2.5 BD Latest Developments
11.3 bioMerieux SA
11.3.1 bioMerieux SA Company Information
11.3.2 bioMerieux SA In Vitro Assays to Diagnose Infectious Diseases Product Offered
11.3.3 bioMerieux SA In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 bioMerieux SA Main Business Overview
11.3.5 bioMerieux SA Latest Developments
11.4 F. Hoffmann-La Roche, Ltd.
11.4.1 F. Hoffmann-La Roche, Ltd. Company Information
11.4.2 F. Hoffmann-La Roche, Ltd. In Vitro Assays to Diagnose Infectious Diseases Product Offered
11.4.3 F. Hoffmann-La Roche, Ltd. In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 F. Hoffmann-La Roche, Ltd. Main Business Overview
11.4.5 F. Hoffmann-La Roche, Ltd. Latest Developments
11.5 Hologic, Inc. (Gen-Probe)
11.5.1 Hologic, Inc. (Gen-Probe) Company Information
11.5.2 Hologic, Inc. (Gen-Probe) In Vitro Assays to Diagnose Infectious Diseases Product Offered
11.5.3 Hologic, Inc. (Gen-Probe) In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Hologic, Inc. (Gen-Probe) Main Business Overview
11.5.5 Hologic, Inc. (Gen-Probe) Latest Developments
11.6 Abbott
11.6.1 Abbott Company Information
11.6.2 Abbott In Vitro Assays to Diagnose Infectious Diseases Product Offered
11.6.3 Abbott In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Abbott Main Business Overview
11.6.5 Abbott Latest Developments
11.7 Quidel Corp.?
11.7.1 Quidel Corp.? Company Information
11.7.2 Quidel Corp.? In Vitro Assays to Diagnose Infectious Diseases Product Offered
11.7.3 Quidel Corp.? In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Quidel Corp.? Main Business Overview
11.7.5 Quidel Corp.? Latest Developments
11.8 iemens Healthineers AG
11.8.1 iemens Healthineers AG Company Information
11.8.2 iemens Healthineers AG In Vitro Assays to Diagnose Infectious Diseases Product Offered
11.8.3 iemens Healthineers AG In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 iemens Healthineers AG Main Business Overview
11.8.5 iemens Healthineers AG Latest Developments
11.9 Bio-Rad Laboratories, Inc.
11.9.1 Bio-Rad Laboratories, Inc. Company Information
11.9.2 Bio-Rad Laboratories, Inc. In Vitro Assays to Diagnose Infectious Diseases Product Offered
11.9.3 Bio-Rad Laboratories, Inc. In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Bio-Rad Laboratories, Inc. Main Business Overview
11.9.5 Bio-Rad Laboratories, Inc. Latest Developments
11.10 Danaher Corp.
11.10.1 Danaher Corp. Company Information
11.10.2 Danaher Corp. In Vitro Assays to Diagnose Infectious Diseases Product Offered
11.10.3 Danaher Corp. In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Danaher Corp. Main Business Overview
11.10.5 Danaher Corp. Latest Developments
11.11 OraSure Technologies, Inc
11.11.1 OraSure Technologies, Inc Company Information
11.11.2 OraSure Technologies, Inc In Vitro Assays to Diagnose Infectious Diseases Product Offered
11.11.3 OraSure Technologies, Inc In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 OraSure Technologies, Inc Main Business Overview
11.11.5 OraSure Technologies, Inc Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global In Vitro Assays to Diagnose Infectious Diseases Market Size (2021-2032)
2.1.2 In Vitro Assays to Diagnose Infectious Diseases Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for In Vitro Assays to Diagnose Infectious Diseases by Country/Region (2021, 2025 & 2032)
2.2 In Vitro Assays to Diagnose Infectious Diseases Segment by Type
2.2.1 Immunoassay
2.2.2 Molecular Diagnosis
2.2.3 Others
2.2.4 In Vitro Assays to Diagnose Infectious Diseases Market Size by Type
2.2.4.1 In Vitro Assays to Diagnose Infectious Diseases Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Type (2021-2026)
2.3 In Vitro Assays to Diagnose Infectious Diseases Segment by Application
2.3.1 Streptococcus
2.3.2 Clostridium Difficile
2.3.3 Candida
2.3.4 Tuberculosis
2.3.5 Others
2.3.6 In Vitro Assays to Diagnose Infectious Diseases Market Size by Application
2.3.6.1 In Vitro Assays to Diagnose Infectious Diseases Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.6.2 Global In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Application (2021-2026)
3 IN VITRO ASSAYS TO DIAGNOSE INFECTIOUS DISEASES MARKET SIZE BY PLAYER
3.1 In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Player
3.1.1 Global In Vitro Assays to Diagnose Infectious Diseases Revenue by Player (2021-2026)
3.1.2 Global In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share by Player (2021-2026)
3.2 Global In Vitro Assays to Diagnose Infectious Diseases Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 IN VITRO ASSAYS TO DIAGNOSE INFECTIOUS DISEASES BY REGION
4.1 In Vitro Assays to Diagnose Infectious Diseases Market Size by Region (2021-2026)
4.2 Global In Vitro Assays to Diagnose Infectious Diseases Annual Revenue by Country/Region (2021-2026)
4.3 Americas In Vitro Assays to Diagnose Infectious Diseases Market Size Growth (2021-2026)
4.4 APAC In Vitro Assays to Diagnose Infectious Diseases Market Size Growth (2021-2026)
4.5 Europe In Vitro Assays to Diagnose Infectious Diseases Market Size Growth (2021-2026)
4.6 Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2021-2026)
5.2 Americas In Vitro Assays to Diagnose Infectious Diseases Market Size by Type (2021-2026)
5.3 Americas In Vitro Assays to Diagnose Infectious Diseases Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC In Vitro Assays to Diagnose Infectious Diseases Market Size by Region (2021-2026)
6.2 APAC In Vitro Assays to Diagnose Infectious Diseases Market Size by Type (2021-2026)
6.3 APAC In Vitro Assays to Diagnose Infectious Diseases Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2021-2026)
7.2 Europe In Vitro Assays to Diagnose Infectious Diseases Market Size by Type (2021-2026)
7.3 Europe In Vitro Assays to Diagnose Infectious Diseases Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases by Region (2021-2026)
8.2 Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size by Type (2021-2026)
8.3 Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL IN VITRO ASSAYS TO DIAGNOSE INFECTIOUS DISEASES MARKET FORECAST
10.1 Global In Vitro Assays to Diagnose Infectious Diseases Forecast by Region (2027-2032)
10.1.1 Global In Vitro Assays to Diagnose Infectious Diseases Forecast by Region (2027-2032)
10.1.2 Americas In Vitro Assays to Diagnose Infectious Diseases Forecast
10.1.3 APAC In Vitro Assays to Diagnose Infectious Diseases Forecast
10.1.4 Europe In Vitro Assays to Diagnose Infectious Diseases Forecast
10.1.5 Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Forecast
10.2 Americas In Vitro Assays to Diagnose Infectious Diseases Forecast by Country (2027-2032)
10.2.1 United States Market In Vitro Assays to Diagnose Infectious Diseases Forecast
10.2.2 Canada Market In Vitro Assays to Diagnose Infectious Diseases Forecast
10.2.3 Mexico Market In Vitro Assays to Diagnose Infectious Diseases Forecast
10.2.4 Brazil Market In Vitro Assays to Diagnose Infectious Diseases Forecast
10.3 APAC In Vitro Assays to Diagnose Infectious Diseases Forecast by Region (2027-2032)
10.3.1 China In Vitro Assays to Diagnose Infectious Diseases Market Forecast
10.3.2 Japan Market In Vitro Assays to Diagnose Infectious Diseases Forecast
10.3.3 Korea Market In Vitro Assays to Diagnose Infectious Diseases Forecast
10.3.4 Southeast Asia Market In Vitro Assays to Diagnose Infectious Diseases Forecast
10.3.5 India Market In Vitro Assays to Diagnose Infectious Diseases Forecast
10.3.6 Australia Market In Vitro Assays to Diagnose Infectious Diseases Forecast
10.4 Europe In Vitro Assays to Diagnose Infectious Diseases Forecast by Country (2027-2032)
10.4.1 Germany Market In Vitro Assays to Diagnose Infectious Diseases Forecast
10.4.2 France Market In Vitro Assays to Diagnose Infectious Diseases Forecast
10.4.3 UK Market In Vitro Assays to Diagnose Infectious Diseases Forecast
10.4.4 Italy Market In Vitro Assays to Diagnose Infectious Diseases Forecast
10.4.5 Russia Market In Vitro Assays to Diagnose Infectious Diseases Forecast
10.5 Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Forecast by Region (2027-2032)
10.5.1 Egypt Market In Vitro Assays to Diagnose Infectious Diseases Forecast
10.5.2 South Africa Market In Vitro Assays to Diagnose Infectious Diseases Forecast
10.5.3 Israel Market In Vitro Assays to Diagnose Infectious Diseases Forecast
10.5.4 Turkey Market In Vitro Assays to Diagnose Infectious Diseases Forecast
10.6 Global In Vitro Assays to Diagnose Infectious Diseases Forecast by Type (2027-2032)
10.7 Global In Vitro Assays to Diagnose Infectious Diseases Forecast by Application (2027-2032)
10.7.1 GCC Countries Market In Vitro Assays to Diagnose Infectious Diseases Forecast
11 KEY PLAYERS ANALYSIS
11.1 QIAGEN
11.1.1 QIAGEN Company Information
11.1.2 QIAGEN In Vitro Assays to Diagnose Infectious Diseases Product Offered
11.1.3 QIAGEN In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 QIAGEN Main Business Overview
11.1.5 QIAGEN Latest Developments
11.2 BD
11.2.1 BD Company Information
11.2.2 BD In Vitro Assays to Diagnose Infectious Diseases Product Offered
11.2.3 BD In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 BD Main Business Overview
11.2.5 BD Latest Developments
11.3 bioMerieux SA
11.3.1 bioMerieux SA Company Information
11.3.2 bioMerieux SA In Vitro Assays to Diagnose Infectious Diseases Product Offered
11.3.3 bioMerieux SA In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 bioMerieux SA Main Business Overview
11.3.5 bioMerieux SA Latest Developments
11.4 F. Hoffmann-La Roche, Ltd.
11.4.1 F. Hoffmann-La Roche, Ltd. Company Information
11.4.2 F. Hoffmann-La Roche, Ltd. In Vitro Assays to Diagnose Infectious Diseases Product Offered
11.4.3 F. Hoffmann-La Roche, Ltd. In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 F. Hoffmann-La Roche, Ltd. Main Business Overview
11.4.5 F. Hoffmann-La Roche, Ltd. Latest Developments
11.5 Hologic, Inc. (Gen-Probe)
11.5.1 Hologic, Inc. (Gen-Probe) Company Information
11.5.2 Hologic, Inc. (Gen-Probe) In Vitro Assays to Diagnose Infectious Diseases Product Offered
11.5.3 Hologic, Inc. (Gen-Probe) In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Hologic, Inc. (Gen-Probe) Main Business Overview
11.5.5 Hologic, Inc. (Gen-Probe) Latest Developments
11.6 Abbott
11.6.1 Abbott Company Information
11.6.2 Abbott In Vitro Assays to Diagnose Infectious Diseases Product Offered
11.6.3 Abbott In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Abbott Main Business Overview
11.6.5 Abbott Latest Developments
11.7 Quidel Corp.?
11.7.1 Quidel Corp.? Company Information
11.7.2 Quidel Corp.? In Vitro Assays to Diagnose Infectious Diseases Product Offered
11.7.3 Quidel Corp.? In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Quidel Corp.? Main Business Overview
11.7.5 Quidel Corp.? Latest Developments
11.8 iemens Healthineers AG
11.8.1 iemens Healthineers AG Company Information
11.8.2 iemens Healthineers AG In Vitro Assays to Diagnose Infectious Diseases Product Offered
11.8.3 iemens Healthineers AG In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 iemens Healthineers AG Main Business Overview
11.8.5 iemens Healthineers AG Latest Developments
11.9 Bio-Rad Laboratories, Inc.
11.9.1 Bio-Rad Laboratories, Inc. Company Information
11.9.2 Bio-Rad Laboratories, Inc. In Vitro Assays to Diagnose Infectious Diseases Product Offered
11.9.3 Bio-Rad Laboratories, Inc. In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Bio-Rad Laboratories, Inc. Main Business Overview
11.9.5 Bio-Rad Laboratories, Inc. Latest Developments
11.10 Danaher Corp.
11.10.1 Danaher Corp. Company Information
11.10.2 Danaher Corp. In Vitro Assays to Diagnose Infectious Diseases Product Offered
11.10.3 Danaher Corp. In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Danaher Corp. Main Business Overview
11.10.5 Danaher Corp. Latest Developments
11.11 OraSure Technologies, Inc
11.11.1 OraSure Technologies, Inc Company Information
11.11.2 OraSure Technologies, Inc In Vitro Assays to Diagnose Infectious Diseases Product Offered
11.11.3 OraSure Technologies, Inc In Vitro Assays to Diagnose Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 OraSure Technologies, Inc Main Business Overview
11.11.5 OraSure Technologies, Inc Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. In Vitro Assays to Diagnose Infectious Diseases Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. In Vitro Assays to Diagnose Infectious Diseases Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Immunoassay
Table 4. Major Players of Molecular Diagnosis
Table 5. Major Players of Others
Table 6. In Vitro Assays to Diagnose Infectious Diseases Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global In Vitro Assays to Diagnose Infectious Diseases Market Size by Type (2021-2026) & ($ millions)
Table 8. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Type (2021-2026)
Table 9. In Vitro Assays to Diagnose Infectious Diseases Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global In Vitro Assays to Diagnose Infectious Diseases Market Size by Application (2021-2026) & ($ millions)
Table 11. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Application (2021-2026)
Table 12. Global In Vitro Assays to Diagnose Infectious Diseases Revenue by Player (2021-2026) & ($ millions)
Table 13. Global In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share by Player (2021-2026)
Table 14. In Vitro Assays to Diagnose Infectious Diseases Key Players Head office and Products Offered
Table 15. In Vitro Assays to Diagnose Infectious Diseases Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global In Vitro Assays to Diagnose Infectious Diseases Market Size by Region (2021-2026) & ($ millions)
Table 19. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Region (2021-2026)
Table 20. Global In Vitro Assays to Diagnose Infectious Diseases Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Country (2021-2026)
Table 24. Americas In Vitro Assays to Diagnose Infectious Diseases Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Type (2021-2026)
Table 26. Americas In Vitro Assays to Diagnose Infectious Diseases Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Application (2021-2026)
Table 28. APAC In Vitro Assays to Diagnose Infectious Diseases Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Region (2021-2026)
Table 30. APAC In Vitro Assays to Diagnose Infectious Diseases Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC In Vitro Assays to Diagnose Infectious Diseases Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Country (2021-2026)
Table 34. Europe In Vitro Assays to Diagnose Infectious Diseases Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe In Vitro Assays to Diagnose Infectious Diseases Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of In Vitro Assays to Diagnose Infectious Diseases
Table 40. Key Market Challenges & Risks of In Vitro Assays to Diagnose Infectious Diseases
Table 41. Key Industry Trends of In Vitro Assays to Diagnose Infectious Diseases
Table 42. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. QIAGEN Details, Company Type, In Vitro Assays to Diagnose Infectious Diseases Area Served and Its Competitors
Table 47. QIAGEN In Vitro Assays to Diagnose Infectious Diseases Product Offered
Table 48. QIAGEN In Vitro Assays to Diagnose Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. QIAGEN Main Business
Table 50. QIAGEN Latest Developments
Table 51. BD Details, Company Type, In Vitro Assays to Diagnose Infectious Diseases Area Served and Its Competitors
Table 52. BD In Vitro Assays to Diagnose Infectious Diseases Product Offered
Table 53. BD In Vitro Assays to Diagnose Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. BD Main Business
Table 55. BD Latest Developments
Table 56. bioMerieux SA Details, Company Type, In Vitro Assays to Diagnose Infectious Diseases Area Served and Its Competitors
Table 57. bioMerieux SA In Vitro Assays to Diagnose Infectious Diseases Product Offered
Table 58. bioMerieux SA In Vitro Assays to Diagnose Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. bioMerieux SA Main Business
Table 60. bioMerieux SA Latest Developments
Table 61. F. Hoffmann-La Roche, Ltd. Details, Company Type, In Vitro Assays to Diagnose Infectious Diseases Area Served and Its Competitors
Table 62. F. Hoffmann-La Roche, Ltd. In Vitro Assays to Diagnose Infectious Diseases Product Offered
Table 63. F. Hoffmann-La Roche, Ltd. In Vitro Assays to Diagnose Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. F. Hoffmann-La Roche, Ltd. Main Business
Table 65. F. Hoffmann-La Roche, Ltd. Latest Developments
Table 66. Hologic, Inc. (Gen-Probe) Details, Company Type, In Vitro Assays to Diagnose Infectious Diseases Area Served and Its Competitors
Table 67. Hologic, Inc. (Gen-Probe) In Vitro Assays to Diagnose Infectious Diseases Product Offered
Table 68. Hologic, Inc. (Gen-Probe) In Vitro Assays to Diagnose Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Hologic, Inc. (Gen-Probe) Main Business
Table 70. Hologic, Inc. (Gen-Probe) Latest Developments
Table 71. Abbott Details, Company Type, In Vitro Assays to Diagnose Infectious Diseases Area Served and Its Competitors
Table 72. Abbott In Vitro Assays to Diagnose Infectious Diseases Product Offered
Table 73. Abbott In Vitro Assays to Diagnose Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Abbott Main Business
Table 75. Abbott Latest Developments
Table 76. Quidel Corp.? Details, Company Type, In Vitro Assays to Diagnose Infectious Diseases Area Served and Its Competitors
Table 77. Quidel Corp.? In Vitro Assays to Diagnose Infectious Diseases Product Offered
Table 78. Quidel Corp.? In Vitro Assays to Diagnose Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Quidel Corp.? Main Business
Table 80. Quidel Corp.? Latest Developments
Table 81. iemens Healthineers AG Details, Company Type, In Vitro Assays to Diagnose Infectious Diseases Area Served and Its Competitors
Table 82. iemens Healthineers AG In Vitro Assays to Diagnose Infectious Diseases Product Offered
Table 83. iemens Healthineers AG In Vitro Assays to Diagnose Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. iemens Healthineers AG Main Business
Table 85. iemens Healthineers AG Latest Developments
Table 86. Bio-Rad Laboratories, Inc. Details, Company Type, In Vitro Assays to Diagnose Infectious Diseases Area Served and Its Competitors
Table 87. Bio-Rad Laboratories, Inc. In Vitro Assays to Diagnose Infectious Diseases Product Offered
Table 88. Bio-Rad Laboratories, Inc. In Vitro Assays to Diagnose Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Bio-Rad Laboratories, Inc. Main Business
Table 90. Bio-Rad Laboratories, Inc. Latest Developments
Table 91. Danaher Corp. Details, Company Type, In Vitro Assays to Diagnose Infectious Diseases Area Served and Its Competitors
Table 92. Danaher Corp. In Vitro Assays to Diagnose Infectious Diseases Product Offered
Table 93. Danaher Corp. In Vitro Assays to Diagnose Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Danaher Corp. Main Business
Table 95. Danaher Corp. Latest Developments
Table 96. OraSure Technologies, Inc Details, Company Type, In Vitro Assays to Diagnose Infectious Diseases Area Served and Its Competitors
Table 97. OraSure Technologies, Inc In Vitro Assays to Diagnose Infectious Diseases Product Offered
Table 98. OraSure Technologies, Inc In Vitro Assays to Diagnose Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. OraSure Technologies, Inc Main Business
Table 100. OraSure Technologies, Inc Latest Developments
Table 1. In Vitro Assays to Diagnose Infectious Diseases Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. In Vitro Assays to Diagnose Infectious Diseases Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Immunoassay
Table 4. Major Players of Molecular Diagnosis
Table 5. Major Players of Others
Table 6. In Vitro Assays to Diagnose Infectious Diseases Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global In Vitro Assays to Diagnose Infectious Diseases Market Size by Type (2021-2026) & ($ millions)
Table 8. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Type (2021-2026)
Table 9. In Vitro Assays to Diagnose Infectious Diseases Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global In Vitro Assays to Diagnose Infectious Diseases Market Size by Application (2021-2026) & ($ millions)
Table 11. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Application (2021-2026)
Table 12. Global In Vitro Assays to Diagnose Infectious Diseases Revenue by Player (2021-2026) & ($ millions)
Table 13. Global In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share by Player (2021-2026)
Table 14. In Vitro Assays to Diagnose Infectious Diseases Key Players Head office and Products Offered
Table 15. In Vitro Assays to Diagnose Infectious Diseases Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global In Vitro Assays to Diagnose Infectious Diseases Market Size by Region (2021-2026) & ($ millions)
Table 19. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Region (2021-2026)
Table 20. Global In Vitro Assays to Diagnose Infectious Diseases Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Country (2021-2026)
Table 24. Americas In Vitro Assays to Diagnose Infectious Diseases Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Type (2021-2026)
Table 26. Americas In Vitro Assays to Diagnose Infectious Diseases Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Application (2021-2026)
Table 28. APAC In Vitro Assays to Diagnose Infectious Diseases Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Region (2021-2026)
Table 30. APAC In Vitro Assays to Diagnose Infectious Diseases Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC In Vitro Assays to Diagnose Infectious Diseases Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Country (2021-2026)
Table 34. Europe In Vitro Assays to Diagnose Infectious Diseases Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe In Vitro Assays to Diagnose Infectious Diseases Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of In Vitro Assays to Diagnose Infectious Diseases
Table 40. Key Market Challenges & Risks of In Vitro Assays to Diagnose Infectious Diseases
Table 41. Key Industry Trends of In Vitro Assays to Diagnose Infectious Diseases
Table 42. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. QIAGEN Details, Company Type, In Vitro Assays to Diagnose Infectious Diseases Area Served and Its Competitors
Table 47. QIAGEN In Vitro Assays to Diagnose Infectious Diseases Product Offered
Table 48. QIAGEN In Vitro Assays to Diagnose Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. QIAGEN Main Business
Table 50. QIAGEN Latest Developments
Table 51. BD Details, Company Type, In Vitro Assays to Diagnose Infectious Diseases Area Served and Its Competitors
Table 52. BD In Vitro Assays to Diagnose Infectious Diseases Product Offered
Table 53. BD In Vitro Assays to Diagnose Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. BD Main Business
Table 55. BD Latest Developments
Table 56. bioMerieux SA Details, Company Type, In Vitro Assays to Diagnose Infectious Diseases Area Served and Its Competitors
Table 57. bioMerieux SA In Vitro Assays to Diagnose Infectious Diseases Product Offered
Table 58. bioMerieux SA In Vitro Assays to Diagnose Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. bioMerieux SA Main Business
Table 60. bioMerieux SA Latest Developments
Table 61. F. Hoffmann-La Roche, Ltd. Details, Company Type, In Vitro Assays to Diagnose Infectious Diseases Area Served and Its Competitors
Table 62. F. Hoffmann-La Roche, Ltd. In Vitro Assays to Diagnose Infectious Diseases Product Offered
Table 63. F. Hoffmann-La Roche, Ltd. In Vitro Assays to Diagnose Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. F. Hoffmann-La Roche, Ltd. Main Business
Table 65. F. Hoffmann-La Roche, Ltd. Latest Developments
Table 66. Hologic, Inc. (Gen-Probe) Details, Company Type, In Vitro Assays to Diagnose Infectious Diseases Area Served and Its Competitors
Table 67. Hologic, Inc. (Gen-Probe) In Vitro Assays to Diagnose Infectious Diseases Product Offered
Table 68. Hologic, Inc. (Gen-Probe) In Vitro Assays to Diagnose Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Hologic, Inc. (Gen-Probe) Main Business
Table 70. Hologic, Inc. (Gen-Probe) Latest Developments
Table 71. Abbott Details, Company Type, In Vitro Assays to Diagnose Infectious Diseases Area Served and Its Competitors
Table 72. Abbott In Vitro Assays to Diagnose Infectious Diseases Product Offered
Table 73. Abbott In Vitro Assays to Diagnose Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Abbott Main Business
Table 75. Abbott Latest Developments
Table 76. Quidel Corp.? Details, Company Type, In Vitro Assays to Diagnose Infectious Diseases Area Served and Its Competitors
Table 77. Quidel Corp.? In Vitro Assays to Diagnose Infectious Diseases Product Offered
Table 78. Quidel Corp.? In Vitro Assays to Diagnose Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Quidel Corp.? Main Business
Table 80. Quidel Corp.? Latest Developments
Table 81. iemens Healthineers AG Details, Company Type, In Vitro Assays to Diagnose Infectious Diseases Area Served and Its Competitors
Table 82. iemens Healthineers AG In Vitro Assays to Diagnose Infectious Diseases Product Offered
Table 83. iemens Healthineers AG In Vitro Assays to Diagnose Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. iemens Healthineers AG Main Business
Table 85. iemens Healthineers AG Latest Developments
Table 86. Bio-Rad Laboratories, Inc. Details, Company Type, In Vitro Assays to Diagnose Infectious Diseases Area Served and Its Competitors
Table 87. Bio-Rad Laboratories, Inc. In Vitro Assays to Diagnose Infectious Diseases Product Offered
Table 88. Bio-Rad Laboratories, Inc. In Vitro Assays to Diagnose Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Bio-Rad Laboratories, Inc. Main Business
Table 90. Bio-Rad Laboratories, Inc. Latest Developments
Table 91. Danaher Corp. Details, Company Type, In Vitro Assays to Diagnose Infectious Diseases Area Served and Its Competitors
Table 92. Danaher Corp. In Vitro Assays to Diagnose Infectious Diseases Product Offered
Table 93. Danaher Corp. In Vitro Assays to Diagnose Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Danaher Corp. Main Business
Table 95. Danaher Corp. Latest Developments
Table 96. OraSure Technologies, Inc Details, Company Type, In Vitro Assays to Diagnose Infectious Diseases Area Served and Its Competitors
Table 97. OraSure Technologies, Inc In Vitro Assays to Diagnose Infectious Diseases Product Offered
Table 98. OraSure Technologies, Inc In Vitro Assays to Diagnose Infectious Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. OraSure Technologies, Inc Main Business
Table 100. OraSure Technologies, Inc Latest Developments
LIST OF FIGURES
Figure 1. In Vitro Assays to Diagnose Infectious Diseases Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. In Vitro Assays to Diagnose Infectious Diseases Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. In Vitro Assays to Diagnose Infectious Diseases Sales Market Share by Country/Region (2025)
Figure 8. In Vitro Assays to Diagnose Infectious Diseases Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Type in 2025
Figure 10. In Vitro Assays to Diagnose Infectious Diseases in Streptococcus
Figure 11. Global In Vitro Assays to Diagnose Infectious Diseases Market: Streptococcus (2021-2026) & ($ millions)
Figure 12. In Vitro Assays to Diagnose Infectious Diseases in Clostridium Difficile
Figure 13. Global In Vitro Assays to Diagnose Infectious Diseases Market: Clostridium Difficile (2021-2026) & ($ millions)
Figure 14. In Vitro Assays to Diagnose Infectious Diseases in Candida
Figure 15. Global In Vitro Assays to Diagnose Infectious Diseases Market: Candida (2021-2026) & ($ millions)
Figure 16. In Vitro Assays to Diagnose Infectious Diseases in Tuberculosis
Figure 17. Global In Vitro Assays to Diagnose Infectious Diseases Market: Tuberculosis (2021-2026) & ($ millions)
Figure 18. In Vitro Assays to Diagnose Infectious Diseases in Others
Figure 19. Global In Vitro Assays to Diagnose Infectious Diseases Market: Others (2021-2026) & ($ millions)
Figure 20. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Application in 2025
Figure 21. Global In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share by Player in 2025
Figure 22. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Region (2021-2026)
Figure 23. Americas In Vitro Assays to Diagnose Infectious Diseases Market Size 2021-2026 ($ millions)
Figure 24. APAC In Vitro Assays to Diagnose Infectious Diseases Market Size 2021-2026 ($ millions)
Figure 25. Europe In Vitro Assays to Diagnose Infectious Diseases Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size 2021-2026 ($ millions)
Figure 27. Americas In Vitro Assays to Diagnose Infectious Diseases Value Market Share by Country in 2025
Figure 28. United States In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Region in 2025
Figure 33. APAC In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Type (2021-2026)
Figure 34. APAC In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Application (2021-2026)
Figure 35. China In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 39. India In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Country in 2025
Figure 42. Europe In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Type (2021-2026)
Figure 43. Europe In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Application (2021-2026)
Figure 44. Germany In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 45. France In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 46. UK In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Application (2021-2026)
Figure 52. Egypt In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 58. APAC In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 59. Europe In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 61. United States In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 62. Canada In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 63. Mexico In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 64. Brazil In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 65. China In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 66. Japan In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 67. Korea In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 69. India In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 70. Australia In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 71. Germany In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 72. France In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 73. UK In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 74. Italy In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 75. Russia In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 76. Egypt In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 77. South Africa In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 78. Israel In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 79. Turkey In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 80. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 1. In Vitro Assays to Diagnose Infectious Diseases Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. In Vitro Assays to Diagnose Infectious Diseases Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. In Vitro Assays to Diagnose Infectious Diseases Sales Market Share by Country/Region (2025)
Figure 8. In Vitro Assays to Diagnose Infectious Diseases Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Type in 2025
Figure 10. In Vitro Assays to Diagnose Infectious Diseases in Streptococcus
Figure 11. Global In Vitro Assays to Diagnose Infectious Diseases Market: Streptococcus (2021-2026) & ($ millions)
Figure 12. In Vitro Assays to Diagnose Infectious Diseases in Clostridium Difficile
Figure 13. Global In Vitro Assays to Diagnose Infectious Diseases Market: Clostridium Difficile (2021-2026) & ($ millions)
Figure 14. In Vitro Assays to Diagnose Infectious Diseases in Candida
Figure 15. Global In Vitro Assays to Diagnose Infectious Diseases Market: Candida (2021-2026) & ($ millions)
Figure 16. In Vitro Assays to Diagnose Infectious Diseases in Tuberculosis
Figure 17. Global In Vitro Assays to Diagnose Infectious Diseases Market: Tuberculosis (2021-2026) & ($ millions)
Figure 18. In Vitro Assays to Diagnose Infectious Diseases in Others
Figure 19. Global In Vitro Assays to Diagnose Infectious Diseases Market: Others (2021-2026) & ($ millions)
Figure 20. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Application in 2025
Figure 21. Global In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share by Player in 2025
Figure 22. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Region (2021-2026)
Figure 23. Americas In Vitro Assays to Diagnose Infectious Diseases Market Size 2021-2026 ($ millions)
Figure 24. APAC In Vitro Assays to Diagnose Infectious Diseases Market Size 2021-2026 ($ millions)
Figure 25. Europe In Vitro Assays to Diagnose Infectious Diseases Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size 2021-2026 ($ millions)
Figure 27. Americas In Vitro Assays to Diagnose Infectious Diseases Value Market Share by Country in 2025
Figure 28. United States In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Region in 2025
Figure 33. APAC In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Type (2021-2026)
Figure 34. APAC In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Application (2021-2026)
Figure 35. China In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 39. India In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Country in 2025
Figure 42. Europe In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Type (2021-2026)
Figure 43. Europe In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Application (2021-2026)
Figure 44. Germany In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 45. France In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 46. UK In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share by Application (2021-2026)
Figure 52. Egypt In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries In Vitro Assays to Diagnose Infectious Diseases Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 58. APAC In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 59. Europe In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 61. United States In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 62. Canada In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 63. Mexico In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 64. Brazil In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 65. China In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 66. Japan In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 67. Korea In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 69. India In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 70. Australia In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 71. Germany In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 72. France In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 73. UK In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 74. Italy In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 75. Russia In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 76. Egypt In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 77. South Africa In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 78. Israel In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 79. Turkey In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
Figure 80. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries In Vitro Assays to Diagnose Infectious Diseases Market Size 2027-2032 ($ millions)
